Search clinical trials for: PHY606
Total 1 results
-
Sheng-Teng HuangCompleted
Sponsors and Collaborators
- Alfred Hospital Intensive Care Unit Australia
- Cooperative Clinical Drug Research and Development AG (CCDRD AG)
- Canadian Hemophilia Society
- InfraScan, Inc.
- RINO ZUID
- Deutsche Arthrose-Hilfe
- Shamir Optical Industry Ltd
- The First Affiliated Hospital of Air Force Medicial University
- Centre Hospitalier de Bastia
- Faculdade de Medicina da Universidade do Porto (FMUP)
- Institute of Antibiotics, Huashan Hospital, Fudan University
- Jiajie Chen
- Delosis Limited
- Jikei University School of Medicine
- Research Unit of General Practice, Odense
- Stefania Basili
- Donna Hammond, PhD
- University of Natural Resources and Life Sciences, Vienna, Austria
- Prof. Jürgen Kuschyk, M.D
- IDRI Corporation
- View Full List
Medical Conditions
- Ovarian Aging
- Open Reduction and Internal Fixation
- Incompetence, Functional
- Reduction, Weight
- UP in Online Group Format
- Asian Consortium
- Neovascular Age-related Macular Degeneration(nAMD)
- Autosomal Dominant Hypocalcaemia
- Refractory Transformed B-Cell Non-Hodgkin Lymphoma
- Sepsis and Coagulopathy
- HIV Related Insulin Resistance
- Community-Acquired Staphylococcus Aureus
- Sensory Reconstruction of Digits
- Colonic Adenoma
- Subgluteal Sciatic Block
- Insulin-Dependent Diabetes Mellitus
- Surgery Induced Tissue Adhesions
- Robot-assisted Laparoscopic Prostatectomy Under General Anesthesia
- Oxidative Stress in Patient With Haemoglobinopathy and Affect it of Endocrine System
- Acute Myocardial Infarction, of Inferolateral Wall
- View Full List
Drug Interventions
- INCB7839
- LIS 18 U
- Atorvastatin, 10mg, 20mg, 40mg
- Rosuvastatin calcium tablets
- Chlorcyclizine HCl
- Epoetin beta (NeoRecormon®)
- JR-141
- Hypertonic saline
- Propranolol Hydrochloride Extended Release Capsules 160 mg
- Nanoliposomal Irinotecan
- Gemcitabine (mg/m²)
- Radioligand (11C)AZD2184
- Domperidone
- 13 valent pneumococcal conjugate vaccine and 23 valent pneumococcal polysaccharide vaccine
- PF regimen (cis-platinum ; 5-fluorouracil ) combined with PD-1 inhibitors（pembrolizumab）
- Prucalopride
- HLX23
- Arm 1 - GEH120714 (18F) Injection
- Moxifloxacin
- Sorafenib and OSI-906
- View Full List
CROs by country
- Contract Research Organizations in Croatia
- Contract Research Organizations in Ecuador
- Contract Research Organizations in Hong Kong
- Contract Research Organizations in Kyrgyzstan
- Contract Research Organizations in Mauritania
- Contract Research Organizations in Moldova
- Contract Research Organizations in Nigeria
- Contract Research Organizations in Pakistan
- Contract Research Organizations in Panama
- Contract Research Organizations in Paraguay
- Contract Research Organizations in Poland
- Contract Research Organizations in Slovakia
- Contract Research Organizations in Türkiye
- CRO list by country